IBA Molecular has opened production and distribution of zirconium-89 for preclinical and investigational use with PET for distribution five days a week.

MRI soon after a mild concussion, or mild traumatic brain injury (mTBI), can detect small lesions and may help refine treatment for people with mTBI, according to research that will be presented at the American Academy of Neurology annual meeting in San Diego, March 16 to 23.

Lantheus Medical Imaging has appointed Cesare Orlandi, MD, to serve as its next chief medical officer (CMO).

Dexmedetomidine (DEX), approved in 2008 by the FDA for use in sedation, may offer a safe, effective and efficient alternative to sedatives currently used in pediatric nuclear medicine imaging, according to a study published in the February edition of Radiology. DEX presents itself as a safer method of sedation during a time of growing demand for pediatric PET oncologic and epileptic scanning.

A diffusion tensor imaging (DTI) study has shown that multiple sclerosis (MS) patients with cognitive problems have more damage to areas of the brain involved with cognitive processes compared with MS patients who don’t suffer from cognitive problems, according to the results of the study published online March 6 in Neurology.

I have been talking to various audiences over the past five years about the potential of molecular imaging in the care of our patients.

While there has been a movement toward the advocacy of the use of PET imaging for the detection of coronary artery disease (CAD) due to higher resolution and new promising tracers, but whether the modality will trump CT or SPECT as the gold standards remains to be seen.

The ripple effect of the obesity epidemic is felt through the entire healthcare system, and for molecular imaging, it affects safety, efficiency and diagnostic quality.